Nausea, vomiting, diarrhoea, constipation, and abdominal discomfort affect a significant proportion of patients, though symptoms typically improve over time as the body adjusts to the medication
may escalate to 1 mg or 2 mg weekly based on glycaemic response For oral semaglutide (Rybelsus) used in type 2 diabetes: Starting dose: 3 mg once daily for 30 days Increase to 7 mg once daily
Microarray analysis has identified GHR as one of the top eight genes upregulated by BPC-157, with a 2.29-fold increase in expression
Intriguingly, although SF3B1 does not possess a direct role in MAPK pathway signal transduction, there is little overlap between tumors with MAPK pathway mutations and SF3B1 -mutated tumors, suggesting that SF3B1 mutations possibly lead to splicing variations of specific genes that can lead to MAPK activation (118)
Beyond Weight Loss: Other Emerging Uses of Microdosing in Healthcare Microdosing is an area of research that is showing more and more promise